+86-29-88453375
Ikhaya-ulwazi-

Okuqukethwe

I-NAD+ iqhudelana ne-NMN: Umhlahlandlela Wokwakha Wokutholwa Kwenqwaba

Sep 15, 2026

I-NAD+ iqhudelana ne-NMN ingomunye wemibuzo ejwayeleke kakhulu esiyiletha emaqenjini okuthenga nokwakha esigabeni sokuphila isikhathi eside. Womabili amagama avela kumalebula omkhiqizo afanayo-aphelile, nokho aziphatha ngendlela ehluke kakhulu eshidini elicacisiwe, egumbini lokugcwalisa amakhepisi, noma esimemezelweni samasiko. Lo mhlahlandlela ubhalelwe abathengi be-B2B: abantu abakhetha impahla eluhlaza, bavikele imininingwane kumbuyekezi we-QA, bese kufanele bayithole futhi ngekota elandelayo. Iqhathanisa lezi zinto zombili njengezithako zohwebo, ichaza ukuthi i-NMNH ingena kuphi, ibeka imibhalo okufanele ifuneke, futhi ifingqa isithombe sokulawula e-US, EU naseJapan. Uma uhlolai-beta-nicotinamide mononucleotide (NMN)noma i-NAD+ esikalini sezentengiso, umehluko ongezansi unquma izindleko, isikhathi sokuhola nokuhambisana nelebula.

I-NAD+ iqhudelana ne-NMN ngeMigomo Engenalutho: I-NAD+ Yenqaba kanye Nomqondo Wokulandela

Ukwenqaba ukutholakala kwe-NAD+ kuyisici esivamile sokuguga kwemetabolism, yingakho lesi sigaba sesithako sikhona. Ngokwamagama okwakhiwa umehluko ulula: I-NAD+ (nicotinamide adenine dinucleotide) amaseli e-coenzyme empeleni asebenzisa - imali eqediwe. I-NMN (i-nicotinamide mononucleotide) iyisandulela esiqondile, isinyathelo esisodwa se-enzymatic esikhuphuka nomfula we-NAD+ endleleni yokuhlenga.

Kumthengi, umbuzo othokozisayo ngokwebhayoloji akuwona owokuhweba. Ngasohlangothini lokuthola usizo, okubalulekile ukuthi i-NAD+ elethwe ngomlomo ichayeke ekonakalisweni ngama-enzyme afana ne-CD38, ENPP1 ne-CD73 ngaphambi kokumuncwa kahle. Kungakho inqwaba ye-NAD+ ivamise ukuthengelwa amasistimu okulethwa okukhethekile, kuyilapho i-NMN iyisandulela esisebenzayo samafomethi avamile omlomo. Lokhu yiumkhawulo wokwenza, hhayi isicelo sezempilo; ingxoxo-yedatha yomuntu ingeyezincwadi zomtholampilo, hhayi i-oda lokuthenga.

Sigcina ngamabomu i-molecule-yezinga lebhayoloji kanye nobufakazi bomuntu obushicilelwe kumchazi ohlukile - sibone ukuqhathanisa kwethu kwangaphambiliIzinzuzo ze-NAD+ vs NMN ziqhathaniswa. Lesi sihloko sihlala ngasohlangothini lokuthola usizo.

I-NMN vs NAD+ vs NMNH - Yini Empeleni Ehlukile?

I-NMNH (encishisiwe i-NMN, i-dihydronicotinamide mononucleotide) ifake amakhathalogi esithako njengesandulela se-NAD+ esisha esinikezwayo, futhi i-NMN iqhudelana ne-NMNH manje isiwumbuzo ophindaphindayo kumafuphi okwakhiwa. Umehluko emithathu ubalulekile edeskini lokuthenga.

  • Ukuvuthwa kwezohwebo.I-NMN inesisekelo sabahlinzeki esijulile kanye nesakhiwo sebanga esiqhathaniseka kakhulu, okwenza ukulinganisa kuqonde. I-NMNH inikezwa abakhiqizi abambalwa kakhulu, futhi isibonelo esishicilelwe esilawulayo sincane. Kuphathe njengephrojekthi yokufaneleka, hhayi ukushiya{2}}ukushintshwa.
  • Ifomu kanye nemibhalo.I-counter-i-ion kanye nefomu likasawoti lishintsha isisindo se-molecular, i-assay mathematics kanye nesimemezelo selebula. Cela ifomu eliqondile ngokubhala kunokuthi ulithathele egameni lohwebo.
  • Idatha yokuzinza.Ku-molecule entsha, umthwalo wobufakazi uhlezi nomthengi: isicelo sokuqinisekisa ubuwena, indlela yokuhlola kanye nedatha yokuzinza kwangempela ngaphambi kokuklama okuzungezile.
Isithako Iqhaza endleleni ye-NAD+ Amafomu okuhweba ongabuza ngawo Ukuzinza nokuphatha amanothi
-I-NMN Isandulela esiqondile, isinyathelo esisodwa se-enzymatic esikhuphuka nomfula we-NAD+ I-crystalline powder emabangeni aphezulu-okuhlanzeka; i-liposomal pre{1}}ukuhlakazeka I-Hygroscopic kanye nomswakama-iyazwela; qinisekisa imininingwane yomswakama, ukupakishwa kanye{1}}nedatha yempilo yeshelufu
NAD+ I-coenzyme esebenzayo ngokwayo I-asidi yamahhala noma usawoti we-sodium; i-liposomal dispersions Futhi i-hygroscopic; qinisekisa-i-ion yokubala, njengoba ithinta ukubala kokuhlola nokumenyezelwa kwelebula
I-NMNH (i-NMN eyehlisiwe) I-analogue encishisiwe ye-nicotinamide dinucleotide; ukuma kwesandulela okuvelayo Amabanga ezentengiselwano anomkhawulo Entsha emakethe; qinisekisa ubunikazi, indlela yokuhlola nokuzinza ngaphambi kokufaneleka

NMN, NAD+ and NMNH raw material powder forms compared in glass sample dishes

Amafomu angenhla abonisa izethulo zemakethe, hhayi ukuzibophezela okucacisiwe kwanoma yimuphi umphakeli. Qinisekisa ifomu, i-assay, counter-ion kanye nempilo yeshelufu eshidini lesicaciso kanye nesitifiketi sokuhlaziya (COA) sebanga ohlose ukulithenga.

Ukuzinza, Ukuhlanzeka kanye Nombuzo Wokulethwa

Bulk NAD+ and NMN ingredient powder samples in glass dishes on a stainless steel laboratory bench

Ukuzinza kulapho iziqhathaniso eziningi zesithako zigcina khona, futhi okuguquguqukayo okuvamise ukushoda kukhotheshini. Kokubili i-NAD+ ne-NMN i-hygroscopic futhi izwela umswakama nokushisa ngesikhathi sokugcinwa nokucubungula. Ibanga elithatha amanzi egumbini lokugcwalisa elinomswakama lizophela, lilahlekelwe ukugeleza, futhi likhukhuleke ekucacisweni phakathi kwedethi ye-COA kanye nokuphela okumenyezelwe kweshelufu - ukwehluleka okuvela endaweni yemakethe, hhayi endaweni yokugcina impahla.

Yingakho ifomethi yokulethwa iwukuhluka okukhethiwe kwangempela, hhayi indaba yokumaketha. I-encapsulation ku-phospholipid bilayer - umzila we-liposomal - yakhelwe ukuvikela okusebenzayo kumswakama, umoya-mpilo nokukhanya ngesikhathi sokulondoloza kanye nokuguqula indlela ehlakazeka ngayo ku-matrix eqediwe. Abathengi beqhathanisaliposomal NMN powderngeliposomal NAD+ powderkufanele iqhathanise izinto ezintathu: ukusebenza kahle kwe-encapsulation njengesibalo esishiwo, esivivinywayo; ukusatshalaliswa kosayizi wezinhlayiyana; kanye nedatha yokuzinza kumpushana eqediwe - hhayi igama le-molecule eliphrintwe esigubhu.

Lapho amaqembu okuthenga esicela ukuthi sisebenze nge-liposomal NAD+ vs NMN, ubufakazi obunqumayo cishe buhlala bubhalwe phansi. Abahlinzeki ababili abacaphuna i-molecule efanayo ngokuhlanzeka okufanayo bangaletha imikhiqizo ehluke kakhulu uma umuntu engakwazi ukukhiqiza idatha ye-encapsulation esebenza kahle, ukusatshalaliswa kosayizi wezinhlayiyana, noma{2}}idatha yokuzinza yesikhathi sangempela. Izinyathelo ezingokoqobo: cela amasampula ebangeni eliqondile ozolisebenzisa, wabambe ngaphansi kwemibandela yakho yokugcina, futhi uhlole ukuhlakazeka ku-matrix yakho ngaphambi kokwenza iqoqo lezentengiso.

Izinketho zokucaciswa zabathengi abaningi

Akukho ukucaciswa okukodwa "okulungile" kwenqwaba yempushana ye-NMN noma i-NAD+. Kukhona isethi evamile yamapharamitha, nokho, noma yimuphi umphakeli onekhono okufanele akwazi ukukuchaza nokuhlola. Sebenzisa lolu hlu njengomgogodla we-RFQ yakho:

  • Ubunikazi kanye nokuhlolwa.Qinisekisa indlela yokuhlola - I-HPLC iyindinganiso yokusebenza yalawa manucleotide - futhi ucele i-chromatogram emele, hhayi nje iphesenti.
  • Ifomu kanye{0}}ne-ion yokuphikisa.I-asidi yamahhala noma usawoti we-sodium; ishintsha isisindo samangqamuzana, izibalo zokuhlola kanye nesimemezelo selebula.
  • Umswakama.I-Karl Fischer titration, ngomkhawulo indawo yakho yokugcwalisa ingabamba.
  • Izinsimbi ezinzima.I-ICP-MS, enemikhawulo ebekwe ngokumelene nemakethe yendawo oya kuyo (ICH Q3D ne-USP<232>/<233>yizinhlaka ezijwayelekile zokubhekisela).
  • I-Microbiology.Isibalo se-aerobic esiphelele kanye nemvubelo, isikhunta nezinto eziphilayo ezishiwo, ezihlolwe ngokuqhathaniswa nezahluko ze-pharmacopoeial ezifanele (isibonelo i-USP<2021>/<2022>noma EP 2.6.12/2.6.13).
  • Izincibilikisi ezisele, lapho umzila wokukhiqiza uwasebenzisa khona.
  • Usayizi wezinhlayiya nokugeleza, uma ugcwalisa ama-capsules, ama-sachets noma amaphakethe okunamathela.
  • I-Solubility kanye ne-dispersibilityku-matrix yakho ethile: ingxube yempushana, i-capsule, i-RTD.
  • Ukupakisha nempilo yeshelufu, okuhlanganisa ukuvalwa kwesiqukathi kanye nezimo zokulondoloza ezicatshangwayo.

Iphakethe ledokhumenti ozolicela ngaphambi kokufaka i-oda lokuthenga:

  • Ishidi lokucaciswa kwebanga eliqondile elicashuniwe
  • Iqoqo-leSitifiketi Esiqondile Sokuhlaziya esinezindlela zokuhlola ezishiwo
  • Ishidi Ledatha Yezokuphepha
  • Idatha yokuzinza - isheshisiwe, kanye nesikhathi sangempela-
  • Izitatimende ze-Allergen, GMO kanye ne-BSE/TSE
  • Isitifiketi se-Halal / Kosher, lapho imakethe yakho isidinga khona
  • Izwe lendabuko nendawo yokukhiqiza
  • I-MOQ eqinisekisiwe, isikhathi sokuhola nokucushwa kokupakishwa

Imithetho emibili esebenzayo. Okokuqala, intengo ngekhilogremu iqathaniswa kuphela uma i-assay, ifomu nokupakishwa kufana - isilinganiso esishibhile esilinganisweni esiphansi ngokuvamile siyisithako esibiza kakhulu. Okwesibili, phatha "Okukhulu noma okulingana nama-98%" kwikhotheshini njengesimemo sokuqinisekisa esikhundleni sokucaciswa; cela inani le-COA yeqoqo kanye nendlela elikhiqize ngayo. Ngokwenza kwethu, ubumsulwa, i-encapsulation kanye nezinhlayiyana{5}}amanani kasayizi akhishwa ngeqeqebana ngalinye ne-COA, ngakho ithimba le-QA lomkhiqizo lingakwazi ukuhlola elikutholile.

Iqiniso Lokulawula Nokulebula NgeMakethe

Liposomal ingredient production and quality-control laboratory with sample vials and an analytical instrument

Isimo sokulawula, hhayi inani, ngokuvamile umbuzo wokuqala ithimba lokuthobelana lomkhiqizo eliwuphakamisayo - futhi uhluka ngemakethe. Isifinyezo esingezansi sibonisa ulwazi lokulawula olutholakala esidlangalaleni kusukela ngo-September 2026. Kuwukuqondiswa komthombo, hhayi iseluleko sezomthetho; qinisekisa isikhundla samanje nesiphathimandla esifanele noma umxhumanisi olawulayo ngaphambi kokuthi uthumele noma ulebule.

  • I-united states.Ngo-Okthoba 2022, i-FDA yathatha isikhundla sokuthi i-NMN yayikhishiwe encazelweni yesithasiselo sokudla ngaphansi koMthetho we-FD&C, icaphuna uphenyo lwayo lwangaphambili lwezidakamizwa. Ngemuva kwezicelo zemboni nokumangalelana, leso sikhundla sahoxiswa ngasekupheleni kukaSepthemba 2025, futhi i-ejensi yabuyisela ngokusemthethweni isimo sesithako esisha sokudla (i-NDI) ngomhla ka-2 Disemba 2025, ngezincwadi zezimpendulo ezishicilelwe ngomhla ka-9 Disemba 2025. Hlola izinsiza zesithako se-FDA ngerekhodi lamanje.
  • Iyuniyani yase-Europe.I-NMN iphathwa njengokudla okunoveli ngaphansi koMthethonqubo (EU) 2015/2283, ngakho-ke angeke ibekwe emakethe ye-EU njengesithasiselo sokudla ize igunyazwe futhi ifakwe ohlwini. I-EFSA Panel on Nutrition, Novel Foods and Food Allergens yashicilela umbono wesayensi omuhle ngo-May 2026 mayelana ne-chemical synthesized -NMN ehloselwe ukusetshenziswa ezithasiselweni zokudla njengomthombo we-niacin ofika ku-300 mg/ngosuku kubantu abadala, ngaphandle kwabesifazane abakhulelwe nabancelisayo. Umbono we-EFSA isinyathelo esisodwa; ukugunyazwa kuyinqubo ehlukile. Hlola ikhathalogi ye-EU Novel Food ngaphambi kokuthengisa.
  • Japan.I-NMN-imikhiqizo equkethe imakethwa ngomzila we-Foods with Functional Claims (FFC): umthengisi uthumela isaziso ku-Ejensi Yezindaba Zabathengi futhi usekela isimangalo ngobufakazi. Idatha yokugcwaliswa komphakathi ibonisa okungu-13 NMN{3}}equkethe imikhiqizo ye-FFC ebhaliswe phakathi kuka-2023 no-2025, enezimangalo ezigxile ekhonweni lokuhamba, ikhwalithi yokulala kanye nomswakama wesikhumba kubantu abadala abachaziwe. I-FFC iyisaziso{7}isekelwe, futhi umthwalo wemfanelo wesimangalo usemahlombe ofake ifayili - obeka iphekhi yobufakazi kuhlelo lwakho lokukhuthala, hhayi kuphela uhlelo lwakho lokumaketha.

Kusho ukuthini lokhu ngesinqumo sokuthola usizo:isimangalo esiqediwe-somkhiqizo ongasenza singaphansi kwemakethe othengisa kuyo. Cela umphakeli wakho amadokhumenti asekela ukufaka kwakho - ukwakheka, inqubo, imininingwane ecacisiwe kanye nedatha yokuzinza - ngefomethi esebenzisekayo.

FAQ

Uyini umehluko phakathi kwe-NAD+ ne-NMN njengezithako eziyinqwaba?
I-NAD+ iyi-coenzyme esebenzayo; I-NMN iyisandulela esiqondile umzimba oguqulela kuso. Njengezinto zokusetshenziswa ezithengiwe, umehluko ongokoqobo ukulethwa: i-NAD+ elawulwa ngomlomo ichayeka ekulimaleni okungaphandle kwamaseli ngaphambi kokumuncwa kahle, ngakho imvamisa icaciswa kumasistimu okulethwa okukhethekile, kuyilapho i-NMN iyinketho evamile yamafomethi omlomo. Kokubili kudinga ukulawulwa komswakama okuqinile kanye{4}}nemibhalo yokuhlaziya yeleveli yeqoqo.

I-NMN iqhudelana ne-NMNH - imuphi umdidiyeli okufanele ayicabangele?
I-NMN inesisekelo esibanzi sabahlinzeki, isakhiwo sebanga esiqhathaniseka kakhulu kanye nesandulela esilawulayo, okuyenza ibe indawo ephansi{0}}engozini yokuqala. I-NMNH yintsha ekumaketheni ngamamaki ambalwa okuhweba; ingahlolwa, kodwa iphathe njengephrojekthi yeziqu edinga ukuqinisekiswa kobunikazi, indlela yokuhlola kanye nedatha yokuzinza.

Ingabe i-liposomal NAD+ ingcono kune-NMN yomkhiqizo wokungeza?
Baphendula imibuzo ehlukene. Ukulethwa kwe-Liposomal kubhekana nokuzinza nokuhlakazeka kokusebenza ku-matrix eqediwe; ukukhetha phakathi kwama-molecule kuqhutshwa isimangalo sakho, ifomethi kanye nemakethe. Ukuqhathanisa okuwusizo akulona igama le-molecule kodwa imibhalo: ukusebenza kahle kwe-encapsulation, ukusabalalisa usayizi wezinhlayiyana kanye nedatha yokuzinza ku-powder eqediwe.

Kufanele ngikucacise kanjani ukuhlanzeka kwe-NMN futhi yimiphi imibhalo okufanele ngiyicele?
Misa umkhawulo wakho wokuhlola nge-HPLC, vumelana nefomu-yokuphikisa ngokubhala, futhi ucacise umswakama, izinsimbi ezisindayo kanye nemikhawulo ye-microbiological ngokumelene nemakethe yakho lapho uya khona. Bese ucela ishidi lokucaciswa, inqwaba-i-COA ethile enezindlela zokuhlola ezishiwo, i-SDS, idatha yokuzinza, nezitatimende ze-allergen, i-GMO kanye ne-BSE/TSE. Qinisekisa inani le-COA yeqoqo, hhayi inani lesihloko esiyinhloko.

Yiziphi izimfuneko zokuzinza nokugcinwa kwenqwaba ye-NMN?
I-NMN i-hygroscopic futhi izwela umswakama nokushisa. Igcine ipholile, yomile futhi ivikelekile ekukhanyeni okusemswakameni{1}}ekuhlanganisweni kwesithiyo, gcina isiqukathi sivaliwe phakathi kokusebenza kokukhipha impahla, futhi usebenze kusukela kushelufu kanye nezimo zokugcina ku-COA. Ezindaweni zokugcwalisa ezinomswakama, hlola{3}}umswakama nokugeleza kwasendlini ngaphambi kokwenza inqwaba.

Noma ngabe yiluphi uhlangothi lwesinqumo se-NAD+ ne-NMN okuhlala kuso ukwakheka kwakho, imibhalo ivamise ukunquma umphumela. Uma ungathanda ukulinganisa amabanga,hlola uhla lwethu lwesithako se-liposomalngaphambi kokwazisa umphakeli wakho.

Cela Imininingwane namasampuli

Sitshele ukucaciswa kwakho okuhlosiwe kanye nesicelo, futhi sizokuthumelela ishidi lokucaciswa, iqoqo le-COA kanye nesampula yesivivinyo sakho sebhentshi.

I-imeyili: liu@wellgreenxa.com
Ucingo/WhatsApp: +86-19890982054
Noma sebenzisa ifomu lombuzo elingezansi kokuthi - ngokuvamile siphendula phakathi namahora angu-24.

Imithombo

  1. I-US Food and Drug Administration - Izinsiza zesithako sezithako zokudla. https://www.fda.gov/food/dietary-supplements/information-khetha-dietary-supplement-izithako{11}}kanye{12}}nezinye{13}}izinto
  2. I-NutraIngredients - "I-FDA ithi i-NMN isemthethweni ezithasiselweni zokudla" (30 Septhemba 2025). https://www.nutraingredients.com/Article/2025/09/30/fda-declares{10}}nmn{11}}lewful-in{13}}dietary{14}}supplements/
  3. I-EFSA Journal 2026;24(5):e10007 - Ukuphepha kwe-beta{4}}i-nicotinamide mononucleotide ( -NMN) ngaphansi koMthethonqubo (EU) 2015/2283. https://doi.org/10.2903/j.efsa.2026.10007
  4. I-CIRS Group - Global Regulatory Progress ye-NMN e-US, Australia nase-EU (2 Disemba 2025 ukubuyiselwa kwe-NDI; 9 Disemba 2025 izincwadi zokuphendula). https://www.cirs-group.com/en/food/global-regulatory{10}}inqubekelaphambili{11}}ye{12}}nmn{13}}e-e{15}}e-united{16}}states-australia{1}e-australia{1}e-australia{1}e-australia{1}{8{13}
  5. Iqembu le-CIRS - Uhlolojikelele Lokufakwa Kwelebula Kokudla Okusebenzayo kwe-NMN e-Japan. https://www.cirs-group.com/en/food/overview-of-nmn-functional-ukudla-ilebula{10}}okufakwayo{11}}e{12}}e-japan
Thumela ukuPhenya

Thumela ukuPhenya